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Background: Acute myocarditis (AM) diagnosis is a challenge to rule
out an acute coronary syndrome (ACS). AM is thought to favour the evo-
lution towards dilated cardiomyopathy (DCM) and the occurrence of
severe arrhythmias. Three months after the acute episode, re-evaluation
including cardiac MRI could help to identify patients at risk for unfavour-
able evolution. The use of MRI has rarely been investigated in AM prog-
nosis stratification.
Method and results: we report a prospective series of 43 consecutive
patients hospitalized for AM mimicking ACS: 36 men and 7 women,
32 years old on average, without sign of heart failure. All patients presented
with troponine I elevation. Echocardiography showed moderate global left
ventricular dysfunction in 6 cases and segmental wall motion abnormalities
in 22. MRI performed early after admission never showed myocardial first-
pass perfusion defect after gadolinium injection but subepicardial delayed-
enhancement (DE) areas in 39 cases mainly located in lateral segments.
Three months after the acute episode, no patient was symptomatic. Echocar-
diography, Holter monitoring and biological check-up were normal. MRI
showed the persistence of DE in 23 cases without wall motion abnormality
in the affected segments. The presence of these latter abnormalities led to
effect an annually clinical examination with an ECG. One patient was lost
at further follow-up. Among the other 22 patients, only one patient dys-
played heart failure revealing DCM with ventricular arrhythmias at 3 – year
mean follow-up.
Conclusions: at the time of admission, the absence of early perfusion
defect at cardiac MRI after gadolinium injection and the subepicardial local-
ization of the DE constitute reliable criteria in favour of AM diagnosis,
allowing to rule out ACS. During the follow-up the persistence of a DE does
not allow any prognosis stratification. In our series after a mean 3-year follow-
up, it is not associated with any clinical and para-clinical disorder except in
one case.
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Background: Isolated left ventricular noncompaction (ILVNC) is a
rare cardiomyopathy characterized by deep trabeculations in the ventric-
ular wall which define recesses with the main chamber. The aim of our
study was to compare segmental and global peak systolic longitudinal
strain (pSSL) in ILVNC considering various left ventricular ejection frac-
tion (LVEF).
Methods: 28 patients (17-74 years old, mean age 46±16) with ILVNC
were retrospectively enrolled and compared to 40 controls (group 1). Patients
were divided into two groups according to LVEF group 2=LVEF>50% (n=15)
and group 3 = LVEF≤50% (n=13). pSSL was compared in each 17 left ven-
tricular segments of the 3 groups.
Results: Number of non compacted segments was higher in group 3 than
in group 2 (5.9±1.7 vs 4.6 ±1.3, p=0.008). Tissue Doppler Imaging E' was
lower in group 3 compared with group 1 (p<0.001) whereas E' was not dif-
ferent between groups 1 and 2. Global pSSL (–15.75±4.8 and –22.18±1.9
p<0.001), basal mean (p<0.001), middle mean (p<0.001) and apex mean
(p<0.001) were lower in patients with ILVNC compared to group 1. Basal
mean (p=0.013), middle mean (p<0.001), apex mean (p<0.001) and global
pSSL (–19.07±2.3 and –22.18±1.9 p<0.001) were lower in group 2 compared
to controls. Basal pSSL of normally compacted basal segment in ILVNC were
lower compared to basal pSSL in controls (septum p<0.001; lateral, p=0.009;
inferior, p=0.008; anterior, p=0.009). There was a significant correlation
between the number of non-compacted segments and the global pSSL (r=–0.418,
p=0.027).
Conclusion: Global left ventricular pSSL is reduced in patients with
ILVNC even those with normal LVEF. Even in basal normally compacted
segments, segmental correspondent pSSL is lower in patients with ILVNC
compared to controls. This finding suggests that ILVNC is a diffuse left ven-
tricular cardiomyopathy not only affected non compacted segments. Our
results suggest that pSSL could be an early predictor of left ventricular sys-
tolic dysfunction in ILVNC.
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Background: The aim of the study was to assess the prevalence of sub-
clinical cardiomyopathy among patients with type 2 diabetes without hyper-
tension or coronary artery disease (CAD). Materials and methods: 656 patients
with type 2 diabetes for 14±8 yrs (359 men, 59.7±8.7 years, HbA1c
8.7±2.1%), without cardiac symptom and at least one cardiovascular risk
factor (hypertension 74%; dyslipidemia 70%; smoking habits 22%; peripheral
occlusive arterial disease 10%, nephropathy 39%) had a contributive cardiac
echography at rest; underwent a stress cardiac scintigraphy to screen for silent
myocardial ischemia (SMI), and in case of SMI, a coronary angiography to
screen for silent CAD.
Results: SMI was diagnosed in 206 patients, and 71 of them had silent
CAD. In the patients without hypertension or CAD (n=157), left ventric-
ular hypertrophy (LVH: 24.1%) was the most frequent abnormality, fol-
lowed by left ventricular dilation (8.6%), hypokinesia (5.3%), abnormal
type 1 relaxation (4.8%) and systolic dysfunction (3.8%). No parameter
was associated with LVH neither with LV dilation nor with abnormal
relaxation. In multivariate analysis, the parameters associated with hypo-
kinesia were SMI (Odds ratio 14.7 [2.7-81.7] p<0.01) and peripheral
occlusive arterial disease (OR 12.2 [1.4-103.1] p<0.05); those associated
with systolic dysfunction were SMI (OR 114.6 [1.7-7907], p<0.01),
HbA1c (OR 1.9 [1.1-3.2] p<0.05) and BMI (OR 1.6 [1.1-2.4] p<0.05).
LVH was more prevalent among hypertensive patients (without CAD
34.5%; with CAD 46.7%); and hypokinesia in the patients with CAD
(without hypertension 13.3%, with hypertension 13.7%). 
Conclusion: In asymptomatic type 2 diabetic patients, diabetic cardio-
myopathy is highly prevalent and is characterized by LVH. SMI, obesity
and poor glycemic control contribute to systolic dysfunction and/or hypo-
kinesia. Hypertension is associated with more LVH, and CAD with more
hypokinesia.
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